HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
Artificial Intelligence Powered Rare Disease Diagnosis Research Report 2025: Market to Surpass $5.5 Billion by 2029 on Accelerated Adoption of Predictive and Personalized Healthcare - Forecast to 2034 [Yahoo! Finance]
GeneDx (NASDAQ:WGS) had its price target raised by analysts at Wells Fargo & Company from $95.00 to $140.00. They now have an "equal weight" rating on the stock.
GeneDx to Participate in Upcoming Investor Conferences